UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME - USD ($) shares in Millions, $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Total revenue	$ 511.4	$ 521.1	$ 1,360.0	$ 1,472.7
Total cost of revenue	263.1	267.2	733.2	773.7
Gross profit	248.3	253.9	626.8	699.0
Operating expenses:
Selling, general and administrative	114.6	125.3	338.2	369.9
Research and development	48.3	46.1	140.9	141.0
Other charges (gain), net	4.2	(5.3)	12.2	4.9
Total operating expenses	167.1	166.1	491.3	515.8
Operating income	81.2	87.8	135.5	183.2
Interest and other income (expense), net	(5.9)	(4.6)	(15.4)	(14.0)
Income before income taxes and noncontrolling interest in consolidated subsidiaries	75.3	83.2	120.1	169.2
Income tax provision	20.0	21.7	30.0	40.0
Consolidated net income	55.3	61.5	90.1	129.2
Net income attributable to noncontrolling interests in consolidated subsidiaries	1.0	0.2	1.2	0.6
Net income attributable to Bruker Corporation	$ 54.3	$ 61.3	$ 88.9	$ 128.6
Net income per common share attributable to Bruker Corporation shareholders:
Basic (in dollars per share)	$ 0.35	$ 0.40	$ 0.58	$ 0.83
Diluted (in dollars per share)	$ 0.35	$ 0.39	$ 0.57	$ 0.82
Weighted average common shares outstanding:
Basic (in shares)	153.2	154.2	153.7	155.7
Diluted (in shares)	154.3	155.6	154.8	157.0
Comprehensive income	$ 64.0	$ 26.1	$ 110.1	$ 92.0
Less: Comprehensive income attributable to noncontrolling interests	1.4	0.2	1.5	1.0
Less: Comprehensive income (loss) attributable to redeemable noncontrolling interest		(1.2)	(0.5)	(1.8)
Comprehensive income attributable to Bruker Corporation	62.6	27.1	109.1	92.8
Product
Total revenue	419.6	440.6	1,111.6	1,235.3
Total cost of revenue	210.3	220.4	584.1	627.9
Service
Total revenue	90.0	78.8	244.3	234.8
Total cost of revenue	52.6	46.5	148.4	145.3
Other
Total revenue	1.8	1.7	4.1	2.6
Total cost of revenue	$ 0.2	$ 0.3	$ 0.7	$ 0.5